17–18 NovemberManchester, UK

Welcome

...to Biotech Outsourcing Strategies Manchester 2020

Launched in 2006 by Bio2Business Ltd, the Biotech Outsourcing Strategies Events bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. The established BOS Formula is built on 4 key pillars; Exhibition showcasing international CROs and CMOs; High Quality Content (delivered through the multi-stream programme); 1-to-1 Partnering; Informal Networking (BOS Events are known for being friendly, intimate events, which create the perfect conditions for networking!).

New for 20020 we are delighted to bring the BOS Events to the north of England and to a city synonymous with industrial and technological progression. BOS MANCHESTER 2020 will cover Discovery Outsourcing, Small Molecule CMC Outsourcing and Biologics CMC Outsourcing. We look forward to welcoming you to the events new home in the heart of Manchester.


What's new

Almac confirm exhibition sponsorship of BOS Manchester 2020

Bio2Business is pleased to welcome Almac as an exhibitor sponsor at BOS Manchester 2020, which will take place on the 17th and 18th of November, 2020, at the Congress Centre Basel in Switzerland. The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally.

Read more

CARBOGEN AMCIS Confirm Gold Sponsorship at BOS Manchester 2020

Bio2Business is pleased to welcome CARBOGEN AMCIS as a Gold Sponsor at BOS Manchester 2020. CARBOGEN AMCIS experts will deliver a 15 minute presentation on the 18th November, 10.45-11.00 in the CMC Small Molecule Track and you can meet their delegates at booth number 33. Further details regarding the presentation theme will follow. CARBOGEN AMCIS, a member of the Dishman Group, provide drug development and commercialisation services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development. 

Read more